Arrowhead shareholders elect eight directors, approve executive compensation, ratify KPMG

ARROWHEAD PHARMACEUTICALS, INC.

All eight director nominees elected with majority support; Douglas Ingram received 68.9M for vs 13.8M against.
Advisory vote to approve executive compensation passed with 75.3M for, 7.4M against.
Advisory vote on frequency of future say-on-pay selected 1 year with 79.9M votes.
Ratification of KPMG as independent auditors approved with 101.0M for, 1.2M against.
Over 102.7M shares voted out of 125.1M outstanding; all proposals passed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.